Prognostic value of the 5-SENSE Score to predict focality of the seizure-onset zone as assessed by stereoelectroencephalography: a prospective international multicentre validation study
Authors:
- Alexandra Astner-RohracherAAAlexandra Astner-Rohracher
- Alyssa HoAHAlyssa Ho
- John ArcherJAJohn Archer
- Fabrice BartolomeiFBFabrice Bartolomei
- Milan BrazdilMBMilan Brazdil
- Melita Cacic HribljanMHMelita Cacic Hribljan
- James CastellanoJCJames Castellano
- Irena DolezalovaIDIrena Dolezalova
- Martin Ejler FabriciusMFMartin Ejler Fabricius
- Mercedes Garcés-SanchezMGMercedes Garcés-Sanchez
- Kahina HammamKHKahina Hammam
- Akio IkedaAIAkio Ikeda
Open Access
- 21 August 2024
- journal article
- research article
- Published by BMJ in BMJ Neurology Open
- Vol. 6 (2) , e000765
Abstract
Introduction: Epilepsy surgery is the only curative treatment for patients with drug-resistant focal epilepsy. Stereoelectroencephalography (SEEG) is the gold standard to delineate the seizure-onset zone (SOZ). However, up to 40% of patients are subsequently not operated as no focal non-eloquent SOZ can be identified. The 5-SENSE Score is a 5-point score to predict whether a focal SOZ is likely to be identified by SEEG. This study aims to validate the 5-SENSE Score, improve score performance by incorporating auxiliary diagnostic methods and evaluate its concordance with expert decisions.Methods and analysis: Non-interventional, observational, multicentre, prospective study including 200 patients with drug-resistant epilepsy aged ≥15 years undergoing SEEG for identification of a focal SOZ and 200 controls at 22 epilepsy surgery centres worldwide. The primary objective is to assess the diagnostic accuracy and generalisability of the 5-SENSE in predicting focality in SEEG in a prospective cohort. Secondary objectives are to optimise score performance by incorporating auxiliary diagnostic methods and to analyse concordance of the 5-SENSE Score with the expert decisions made in the multidisciplinary team discussion.Ethics and dissemination: Prospective multicentre validation of the 5-SENSE score may lead to its implementation into clinical practice to assist clinicians in the difficult decision of whether to proceed with implantation. This study will be conducted in accordance with the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (2014). We plan to publish the study results in a peer-reviewed full-length original article and present its findings at scientific conferences.Trial registration number: NCT06138808.Keywords
Funding Information
- Start-up Funding Duke University (N/A)
- Institute of Neurosciences, Mental Health and Addiction (PJT-175056)
- WISS 2025 project 'IDA-Lab Salzburg' (20204-WISS/225/197-2019 and 20102-F1901166-KZP)
- Emerging Leadership Investigator Grant from the Australian National Health and Medical Research Council (APP2017651)
This publication has 20 references indexed in Scilit:
- Learn how to interpret and use intracranial EEG findingsEpileptic Disorders, 2024
- Development and Validation of the 5-SENSE Score to Predict Focality of the Seizure-Onset Zone as Assessed by StereoelectroencephalographyJAMA Neurology, 2021
- Comparative Effectiveness of Stereotactic Electroencephalography Versus Subdural Grids in Epilepsy SurgeryAnnals of Neurology, 2021
- Stereoelectroencephalography Versus Subdural Electrodes for Localization of the Epileptogenic Zone: What Is the Evidence?Neurotherapeutics, 2019
- Increased nationwide use of stereoencephalography for intracranial epilepsy electroencephalography recordingsJournal of Clinical Neuroscience, 2018
- Getting the best outcomes from epilepsy surgeryAnnals of Neurology, 2018
- French guidelines on stereoelectroencephalography (SEEG)Neurophysiologie Clinique, 2018
- Development and validation of nomograms to provide individualised predictions of seizure outcomes after epilepsy surgery: a retrospective analysisThe Lancet Neurology, 2015
- Resective Epilepsy Surgery for Drug-Resistant Focal EpilepsyJAMA, 2015
- Early Surgical Therapy for Drug-Resistant Temporal Lobe EpilepsyJAMA, 2012